文献速递乳腺MR

基于MRI的Delta影像组学预测乳腺癌患者新辅助化疗后腋窝淋巴结病理完全缓解

Delta Radiomics Based on MRI for Predicting Axillary Lymph Node Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer Patients.
PubMed 文献 · Acad Radiol · 2024-09-13

本研究从两个中心纳入319例新辅助化疗前经活检病理证实腋窝淋巴结转移的乳腺癌患者,基于MRI提取腋窝淋巴结新辅助化疗前后的影像组学特征并计算Delta影像组学,联合临床病理因素构建影像组学列线图。列线图由两个Radscore(化疗后及Delta Radscore)与孕激素受体(PR)构成,内部与外部测试集AUC分别为0.894(95%CI 0.877-0.959)和0.903(95%CI 0.801-0.986),校准曲线与决策曲线分析显示良好一致性与临床实用性;借助列线图,不必要的腋窝淋巴结清扫率由60.42%降至21.88%,最终获益率由39.58%升至70.83%。

要点

  • 列线图纳入化疗后Radscore、Delta Radscore及PR,用于预测腋窝淋巴结病理完全缓解。
  • 内部测试集AUC 0.894(95%CI 0.877-0.959),外部测试集AUC 0.903(95%CI 0.801-0.986)。
  • 借助列线图,不必要腋窝淋巴结清扫率由60.42%降至21.88%。

核心结论

  • 影像组学列线图在预测乳腺癌患者新辅助化疗后腋窝淋巴结病理完全缓解方面表现良好,可帮助临床医生识别腋窝病理完全缓解患者并避免不必要的腋窝淋巴结清扫。

研究设计与样本

  • 从两个中心纳入319例接受MRI检查并接受新辅助化疗的患者,新辅助化疗前经活检病理证实存在腋窝淋巴结转移。

关键影像表现/征象

  • 影像组学特征提取自新辅助化疗前(pre-radiomics)和新辅助化疗后(post-radiomics)腋窝淋巴结的兴趣区,并计算新辅助化疗前后特征差值即Delta影像组学。

诊断标准与关键数值

  • 采用方差阈值、selectKbest和最小绝对收缩与选择算子算法筛选影像组学特征,Radscore由所选特征按其各自系数加权线性组合计算。

临床应用与阅片要点

  • 采用单因素和多因素logistic回归筛选临床病理因素与Radscore,并通过多变量logistic回归分析构建影像组学列线图。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop and test a radiomics nomogram based on magnetic resonance imaging (MRI) and clinicopathological factors for predicting the axillary pathologic complete response (apCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients with axillary lymph node (ALN) metastases.

MATERIALS AND METHODS: A total of 319 patients who underwent MRI examination and received NAC treatment were enrolled from two centers, and the presence of ALN metastasis was confirmed by biopsy pathology before NAC. The radiomics features were extracted from regions of interest of ALNs before (pre-radiomics) and after (post-radiomics) NAC. The difference of features before and after NAC, named delta radiomics, was calculated. The variance threshold, selectKbest and least absolute shrinkage and selection operator algorithm were used to select radiomics features. Radscore was calculated by a linear combination of selected features, weighted by their respective coefficients. The univariate and multivariate logistic regression was used to select the clinicopathological factors and radscores, and a radiomics nomogram was built by multivariable logistic regression analysis. The performance of the nomogram was evaluated by the area under the receiver operator characteristic curve (AUC), decision curve analysis (DCA) and calibration curves. Furthermore, to explore the biological basis of radiomics nomogram, 16 patients with RNA-sequence data were included for genetic analysis.

RESULTS: The radiomics nomogram was constructed by two radscores (post- and delta- radscores) and one clinicopathological factor (progesterone hormone, PR), and showed powerful predictive performance in both internal and external test sets, with AUCs of 0.894 (95% confidence interval [CI], 0.877-0.959) and 0.903 (95% CI, 0.801-0.986), respectively. The calibration curves and DCA showed favorable consistency and clinical utility. With the assistance of nomogram, the rate of unnecessary ALND would be reduced from 60.42% to 21.88%, and the rate of final benefit rate would be increased from 39.58% to 70.83%. Moreover, genetic analysis revealed that high apCR prediction scores were associated with the upregulation of immune-mediated genes and pathways.

CONCLUSION: The radiomics nomogram showed great performance in predicting apCR after NAC for breast cancer patients, which could help clinicians to identify patients with apCR and avoid unnecessary axillary lymph node dissection.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Mao N, Bao Y, Dong C, et al. Delta Radiomics Based on MRI for Predicting Axillary Lymph Node Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer Patients. Acad Radiol. 2024. PMID: 39271381. doi:10.1016/j.acra.2024.07.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。